- Home
- ETON vs ILLR Comparison
ETON vs ILLR Comparison
Compare ETON & ILLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETON
- ILLR
- Stock Information
- Founded
- ETON 2017
- ILLR 2015
- Country
- ETON United States
- ILLR United States
- Employees
- ETON N/A
- ILLR N/A
- Industry
- ETON Biotechnology: Pharmaceutical Preparations
- ILLR Investment Managers
- Sector
- ETON Health Care
- ILLR Finance
- Exchange
- ETON Nasdaq
- ILLR Nasdaq
- Market Cap
- ETON 329.8M
- ILLR 304.1M
- IPO Year
- ETON 2018
- ILLR N/A
- Fundamental
- Price
- ETON $14.88
- ILLR $0.83
- Analyst Decision
- ETON Strong Buy
- ILLR
- Analyst Count
- ETON 3
- ILLR 0
- Target Price
- ETON $27.67
- ILLR N/A
- AVG Volume (30 Days)
- ETON 248.9K
- ILLR 567.6K
- Earning Date
- ETON 03-18-2025
- ILLR 03-25-2025
- Dividend Yield
- ETON N/A
- ILLR N/A
- EPS Growth
- ETON N/A
- ILLR N/A
- EPS
- ETON N/A
- ILLR N/A
- Revenue
- ETON $39,011,000.00
- ILLR $45,244,000.00
- Revenue This Year
- ETON $107.69
- ILLR N/A
- Revenue Next Year
- ETON $65.50
- ILLR N/A
- P/E Ratio
- ETON N/A
- ILLR N/A
- Revenue Growth
- ETON 23.29
- ILLR N/A
- 52 Week Low
- ETON $3.03
- ILLR $0.66
- 52 Week High
- ETON $18.41
- ILLR $8.86
- Technical
- Relative Strength Index (RSI)
- ETON 48.54
- ILLR N/A
- Support Level
- ETON $12.73
- ILLR N/A
- Resistance Level
- ETON $15.73
- ILLR N/A
- Average True Range (ATR)
- ETON 1.01
- ILLR 0.00
- MACD
- ETON 0.03
- ILLR 0.00
- Stochastic Oscillator
- ETON 60.91
- ILLR 0.00
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
About ILLR Triller Group Inc. Common Stock
Triller Group Inc is a us-based company that operates its businesses through Triller Corp which operates as a technology platform and AGBA Group Holding Limited operates as an insurance and wealth distribution platform.